Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray, Sundial Growers, and Hexo All Dropped in July

By Howard Smith – Aug 7, 2021 at 11:58AM

Key Points

  • The path to legalization in the U.S. continues to take one step forward and two steps back.
  • Sundial will report second-quarter results on Aug. 12.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tilray announced a surprise profit in its first financial report since its merger with Aphria.

What happened

An interesting development occurred in the cannabis sector last month with a new proposal from congressional leaders in the U.S. to decriminalize marijuana. That's what many proponents have been waiting for, with a Democrat in the White House and the party having a majority in Congress. But support for the proposal didn't go as planned, and Canadian cannabis stocks took a hit.

For the month of July, shares of Tilray (TLRY 4.03%), Sundial Growers (SNDL 5.45%), and Hexo (HEXO 0.48%) dropped 19.2%, 13.1%, and 31.3%, respectively, according to data provided by S&P Global Market Intelligence.

So what

Though there was some good news on the earnings front last month, one thing that continues to move Canadian marijuana stocks is the progress -- or lack thereof -- of federal legalization in the U.S. And there was a potentially important development in July. 

Marijuana leaves on top of $100 bills.

Image source: Getty Images.

Sen. Chuck Schumer and two other Democratic senators drafted a new bill that aims to legalize pot at the federal level and remove marijuana from the Controlled Substances Act. That would be a transitional development for Canadian companies, opening a huge new market. Some, including Tilray, already have business relationships in the U.S. providing them infrastructure to be ready to sell cannabis should federal approval occur.

But after the new bill was drafted, President Biden's press secretary Jen Psaki addressed the topic, stating, "There's no new endorsements of legislation to report today." Lack of support from the president doesn't bode well for any near-term change in policy.

Now what

Canadian cannabis companies have been struggling to rebound from pandemic restrictions that continue to impact their businesses into 2021. On June 14, 2021 Hexo reported growing losses year over year on net sales that increased only 2% for its quarterly period ended April 30, 2021. Hexo CEO Sebastien St-Louis said it had been a "challenging quarter" due to a new wave of COVID-19 infections in Ontario during the quarter and subsequent restrictions on retail operations.

Tilray had some better news from its first quarterly financial report since it closed its merger with Aphria. The company said cannabis revenue grew 55% in its fiscal fourth quarter, and it has gained market share sequentially each month since April 2021. More importantly, Tilray logged a profit with net income of $33.6 million, when analysts expected a loss for the period. The stock rallied on the news, but it wasn't enough to put it in the black for the month. 

As Tilray's results show, these businesses aren't completely reliant on the U.S. Tilray has been expanding beyond Canada in Europe and investors hope that expansion will also profitably grow the company. Sundial Growers reports its second-quarter financial results on Aug. 12, when investors will get a better idea of how its Canadian sales continue to navigate the pandemic impacts. But any progress in the U.S. toward legalization will remain a major factor in how these stocks will perform in the near future. 

Howard Smith owns shares of Tilray, Inc. The Motley Fool recommends HEXO Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray, Inc. Stock Quote
Tilray, Inc.
TLRY
$3.87 (4.03%) $0.15
HEXO Corp. Stock Quote
HEXO Corp.
HEXO
$0.17 (0.48%) $0.00
SNDL Inc.  Stock Quote
SNDL Inc.
SNDL
$2.71 (5.45%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
349%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.